•
Dec 31, 2022

2Seventy Bio Q4 2022 Earnings Report

Total Revenue
$56.2M
Previous year: $16M
+250.4%
EPS
-$0.6
Previous year: -$2.55
-76.5%
Gross Profit
$40.9M
Previous year: $15.6M
+161.4%
Cash and Equivalents
$71M
Previous year: $130M
-45.5%
Free Cash Flow
-$58.6M
Previous year: -$58.4M
+0.4%
Total Assets
$657M
Previous year: $760M
-13.6%

2Seventy Bio

2Seventy Bio